Ajanta Pharma Limited
NSE: AJANTPHARM | Information Technology
Market Fundamentals
Stock Intelligence & News
Ajanta Pharma Ltd (532331)
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd
Read Full Analysis →Ajanta Pharma Limited
Ajanta Pharma Limited has informed the Exchange about Submission of Sustainability Report for FY 2026 |SUBJECT: General Updates
Read Full Analysis →Ajanta Pharma Ltd (532331)
Pls find enclosed herewith Sustainability Report for FY 2026.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Ajanta Pharma Ltd (532331)
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 28, 2026 for Aayush Agrawal, trustee Aayush Agrawal Trust
Read Full Analysis →Ajanta Pharma Limited
Ajanta Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →Ajanta Pharma Ltd (532331)
Pls find enclosed herewith closure of trading window intimation
Read Full Analysis →Ajanta Soya Ltd (519216)
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chander Kala Goyal
Read Full Analysis →Ajanta Soya Ltd (519216)
Annual Report of the Company for the Financial Year 2025-26
Read Full Analysis →Ajanta Soya Ltd (519216)
Notice of the 35th Annual General Meeting of the Members of the Company
Read Full Analysis →Ajanta Soya Ltd (519216)
Newspaper Advertisement - 35th Annual General Meeting of the Company to be held through VC/OAVM
Read Full Analysis →Get instant alerts when AJANTPHARM breaks news
Join investors who track Ajanta Pharma Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for AJANTPHARM?
AJANTPHARM is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Ajanta Pharma Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding AJANTPHARM to your custom watchlist.